Spontaneous Borna disease in sheep and horses: immunophenotyping of inflammatory cells and detection of MHC-I and MHC-II antigen expression in Borna encephalitis lesions.
Borna disease (BD) has been recognized as a virally induced T-cell dependent immunopathological disorder of the central nervous system (CNS), as shown by experimental infection of rats with Borna disease virus (BDV). In contrast to the rat model, little is known about the pathogenesis of spontaneous BD in sheep and horses. The present study describes the brain lesions of 12 ovine and 11 equine cases of naturally occurring BD. A set of monoclonal and polyclonal antibodies was used in order to determine the cells operative in encephalitic lesions and to detect expression of MHC-I and MHC-II products in the brains of affected animals. In all cases investigated, a reaction pattern similar to that reported for the acute phase of BD in experimentally infected rats was noted. In brief, the majority of inflammatory cells in perivascular infiltrates (PVI) as well as parenchymal and meningeal infiltrates were CD3 +. CD4 + cells outnumbered CD8 + cells in PVI as well as in the parenchyma. Macrophages (defined by lysozyme immunoreactivity) were seen less often and B-cells or plasma cells (cells positive for lambda or kappa light chains) were demonstrated at lower numbers. TCR-1 + cells were found on very rare occasions in PVI of some sheep. MHC-I and MHC-II products were constantly expressed on inflammatory cells but inconsistently on astrocytes and neurons. Neuronal degeneration was not a major feature.
Caplazi
P
P
Institute of Veterinary Pathology, Immunopathology Unit, University of Zurich, Switzerland. caplazi@vetpath.unizh.ch
Ehrensperger
F
F
D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D000956:Antigens, Viral / Q000378:metabolism; D001890:Borna Disease / Q000276:immunology* / Q000473:pathology / Q000821:virology; D001891:Borna disease virus / Q000276:immunology; D002460:Cell Line; D004285:Dogs; D004660:Encephalitis / Q000276:immunology / Q000473:pathology / Q000662:veterinary*; D015395:Histocompatibility Antigens Class I / Q000378:metabolism*; D000949:Histocompatibility Antigens Class II / Q000378:metabolism*; D006734:Horse Diseases / Q000276:immunology* / Q000473:pathology / Q000821:virology; D006736:Horses; D016130:Immunophenotyping; D051381:Rats; D012756:Sheep; D012757:Sheep Diseases / Q000276:immunology* / Q000473:pathology / Q000821:virology; D013601:T-Lymphocytes / Q000276:immunology / Q000473:pathology
D000914:Antibodies, Viral; D000956:Antigens, Viral; D015395:Histocompatibility Antigens Class I; D000949:Histocompatibility Antigens Class II